Who founded Biopsense?

Biopsense was founded by Juha Kononen, Marja Tiirola, Veli-Mikko Puupponen.

Who are Biopsense's investors?

Biopsense's investors include Midinvest Management Oy.

Where is Biopsense headquartered?

Biopsense is headquartered in Jyväskylä, FI.

Biopsense

Jyväskylä, FI · 1 known investors

Find your way into Biopsense

133 people in our graph share verified history with the Biopsense team — schools, employers, funds. One of them is your warm intro.

Emmi Kaipiounlockedknows Elina Ruuhilehto · together at University of Jyväskylä (overlapped)

×2knows the team · via University of Jyväskylä

×7knows the team · via University of Helsinki

knows the team · via University of Eastern Finland

knows the team · via JAMK University of Applied Sciences

BiopSense develops an automated cartridge for extracting cell-free nucleic acids (DNA, RNA, cells, proteins) from large blood volumes without centrifugation, aimed at simplifying liquid biopsy sample preparation and transport for cancer diagnostics and monitoring. It serves oncology clinical laboratories and healthcare providers to enable non-invasive cancer treatment monitoring and personalization.

Biotech Healthtech Medical Devices

Founders & leadership

Juha KononenMedical Director, Founder (MD)

Marja Tiirola inCSO, Founder (Prof.)Marja Tiirola holds a Ph.D. in molecular biology and a permanent professorship at a Finnish university; she founded BiopSense in 2019 to develop automated sample preparation technologies for liquid biopsy diagnostics, and has received European funding including an ERC Consolidator Grant and the first Finnish EIC Transition grant.

Veli-Mikko PuupponeninCIO, Founder (MSc)

Petri Kallberg inCEO (B.Eng.)Petri Kallberg holds a B.Eng. and is CEO of Biopsense, which develops automated cartridges for extracting cell-free nucleic acids from blood samples to support liquid biopsy applications in oncology diagnostics. He has prior experience in product management, engineering, business development, and strategic partnerships across connected technologies and digital services.

Elina Ruuhilehto inLaboratory Director (PhD)Elina Ruuhilehto holds a PhD in biosciences and chemistry with doctoral research in receptor-virus interactions and post-doctoral work in oncology diagnostic method development. She joined BiopSense as Laboratory Director in 2020, where she has managed clinical laboratory operations, IVD medical device development, and quality and safety functions.

Investors · 1

Midinvest Management OyJyväskylä

Frequently asked questions

What does Biopsense do?: BiopSense develops an automated cartridge for extracting cell-free nucleic acids (DNA, RNA, cells, proteins) from large blood volumes without centrifugation, aimed at simplifying liquid biopsy sample preparation and transport for cancer diagnostics and monitoring. It serves oncology clinical laboratories and healthcare providers to enable non-invasive cancer treatment monitoring and personalization.
Who founded Biopsense?: Biopsense was founded by Juha Kononen, Marja Tiirola, Veli-Mikko Puupponen.
Who are Biopsense's investors?: Biopsense's investors include Midinvest Management Oy.
Where is Biopsense headquartered?: Biopsense is headquartered in Jyväskylä, FI.